• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Iterative Scopes Expands its Senior Leadership Team

    Viz.ai Raises $100 Million in Series D Funding

    FDA Clears Arterys' AI Mapping and Quantification Tools

    Prometheus Group Sued Over Reused Catheters and Rectal Sensors

    VenoStent's SelfWrap Bioabsorbable Perivascular Wrap Earns Breakthrough Status
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    BMP Medical

    Xact Wire EDM Corp.

    Cirtec Medical

    Trademark Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    BMP Medical

    Xact Wire EDM Corp.

    Cirtec Medical

    Trademark Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    New 'epiCaPture' Test Uses Urine to Detect Prostate Cancer

    Test has been shown to be 70 percent more specific for prostate cancer compared to the blood test currently used by doctors.

    New
    Pictured at the UCD O’Brien Centre for Science is Dr. Antoinette Perry, UCD School of Biology and Environmental Science and UCD Conway Institute. Image courtesy of Nick Bradshaw, Fotonic.
    Related CONTENT
    • OptraSCAN Announces Expansion of Medical Advisory Board
    • Shape Memory Polymer Could Help Treat Open Wounds, Infections, and Cancer
    • FDA Clears Sensus Healthcare's Sculptura Radiation Oncology System
    • Clinical Trial Launches to Develop Breath Test for Multiple Cancers
    • PROCEPT BioRobotics Appoints Chief Financial Officer
    UCD Research and Innovation03.19.19
    Cancer researchers at University College Dublin (UCD) have led the development of a new test which uses urine to detect prostate cancer. Studies have so far shown the test to be 70 percent more specific for prostate cancer compared to the blood test currently used by doctors.
     
    If the new ‘epiCaPture’ test is further validated it could help to more accurately identify which men do or don’t need invasive tests. This means that many men could be spared harsh treatments that often have long-term side effects.
     
    The test could also help to identify aggressive prostate cancer early, so that more patients can be potentially cured of their cancer.
     
    This research was funded through donations from the public to the Irish Cancer Society and funding from Science Foundation Ireland, the US Prostate Cancer Foundation and Movember.
     
    In Ireland 3,500 men are diagnosed with prostate cancer annually. One in three of these cases will be aggressive cancers, and around 500 men die from this disease here every year.
     
    When a man is diagnosed with prostate cancer, he will first find out whether doctors think his prostate cancer is likely to spread to other parts of the body or not. If not, the patient can be monitored regularly by his doctor through “active surveillance”—where regular check-ups and tests are carried out in lieu of immediate treatment. This spares the patient harsh treatments like chemotherapy and radical surgeries that can have life-long side effects like incontinence and erectile dysfunction.
     
    If the man’s prostate cancer is already aggressive—i.e. has spread, or likely to spread beyond the prostate if left untreated—then he has no option but to be treated urgently.
     
    This research was part of an international collaboration led by Dr. Antoinette Perry, Assistant Professor of Cell Biology and Genetics at the UCD School of Biology and Environmental Science and the UCD Conway Institute, and her team, including Eve O’Reilly, a PhD student at UCD and Alexandra Tuzova, an Irish Cancer Society funded PhD student at UCD.
     
    Dr. Perry said, “Prostate cancer is the fourth leading cause of cancer deaths in Ireland so early detection is vital to catch the disease before it spreads. Unfortunately, the tests we have to detect prostate cancer are not entirely accurate. Our research, funded with the support of the Irish Cancer Society and others, is addressing this problem by developing new ways to catch aggressive, potentially lethal prostate cancer from a simple urine test.”
     
    “Over the last four years our research team at University College Dublin has worked with doctors, nurses, patients and other scientists from around Ireland, the UK, USA and Canada to study urine from almost 500 men. We showed that almost 90 percent of men with aggressive prostate cancer have changes in their DNA that we could find in their urine.”
     
    “These changes were absent in healthy men and men with non-aggressive disease. If we can replicate these findings, our research could contribute to a new, more accurate test to help catch aggressive prostate cancer and save lives from this disease.”
     
    Dr. Perry is currently working closely with UCD’s technology transfer team at NovaUCD to bring this test to market. She has recently been awarded Enterprise Ireland funding to validate the epiCaPture technology in the hope that it will be ready for use by doctors to test men for prostate cancer in the coming years.
     
    Dr. Robert O’Connor, Head of Cancer Research at the Irish Cancer Society, said, “This major new research highlights the vital work world-class cancer researchers are doing in UCD and across Ireland to identify new ways to improve the diagnosis of cancer. More work is needed before the potential benefits reach cancer patients. But it does show the potential we have to save more lives from this disease.”
     
    “The Irish Cancer Society can only invest in vital research like this because of the public’s generous support. We currently fund more than 100 researchers across Ireland and are on track to invest €30 million into life-saving cancer research in the decade up to 2020. But we could fund even more research if we had the funds. That’s why Daffodil Day this Friday needs to be the biggest one yet.”
    Related Searches
    • diagnosis
    • cancer
    • institute
    • led
    Related Knowledge Center
    • Diagnostics
    Suggested For You
     OptraSCAN Announces Expansion of Medical Advisory Board OptraSCAN Announces Expansion of Medical Advisory Board
    Shape Memory Polymer Could Help Treat Open Wounds, Infections, and Cancer Shape Memory Polymer Could Help Treat Open Wounds, Infections, and Cancer
    FDA Clears Sensus Healthcare FDA Clears Sensus Healthcare's Sculptura Radiation Oncology System
    Clinical Trial Launches to Develop Breath Test for Multiple Cancers Clinical Trial Launches to Develop Breath Test for Multiple Cancers
    PROCEPT BioRobotics Appoints Chief Financial Officer PROCEPT BioRobotics Appoints Chief Financial Officer
    Smartphone-Based Test Detects Signs of Ovulation in Saliva Smartphone-Based Test Detects Signs of Ovulation in Saliva
    Software Pinpoints Biopsies to Detect Prostate Cancer Software Pinpoints Biopsies to Detect Prostate Cancer
    Simple Urine Test Could Diagnose Bacterial Pneumonia Simple Urine Test Could Diagnose Bacterial Pneumonia
    Smart Device Allows Early Intervention of Congestive Heart Failure Smart Device Allows Early Intervention of Congestive Heart Failure
    New Blood Test Detects Early Stage Ovarian Cancer New Blood Test Detects Early Stage Ovarian Cancer
    Pacey MedTech Announces Solution to Post-Prostate Cancer Treatment Urinary Incontinence Pacey MedTech Announces Solution to Post-Prostate Cancer Treatment Urinary Incontinence
    'Universal' Blood Test for Earlier Cancer Diagnosis Moves Closer to Market
    Embolx Earns CE Mark Certification for Sniper Balloon Occlusion Microcatheters Embolx Earns CE Mark Certification for Sniper Balloon Occlusion Microcatheters
    First U.S. Prostate Surgery Performed with Single Port SP Robot First U.S. Prostate Surgery Performed with Single Port SP Robot

    Related Content

    •  OptraSCAN Announces Expansion of Medical Advisory Board

      OptraSCAN Announces Expansion of Medical Advisory Board

      Strategic medical advisors appointed to guide on neuropathology, immunology, and molecular pathology research.
      Business Wire 03.01.19

    • Materials
      Shape Memory Polymer Could Help Treat Open Wounds, Infections, and Cancer

      Shape Memory Polymer Could Help Treat Open Wounds, Infections, and Cancer

      New rubbery "smart" material doesn't require additional triggers like temperature changes and could have major implications for healthcare treatment.
      Syracuse University 02.27.19

    • Surgical
      FDA Clears Sensus Healthcare

      FDA Clears Sensus Healthcare's Sculptura Radiation Oncology System

      Sculptura is a robotic Intraoperative Radiation Therapy (IORT) system that uses patented Beam Sculpting capabilities to treat various cancers during surgery.
      Sensus Healthcare 02.27.19


    • Diagnostics
      Clinical Trial Launches to Develop Breath Test for Multiple Cancers

      Clinical Trial Launches to Develop Breath Test for Multiple Cancers

      Study will use Owlstone Medical’s Breath Biopsy platform to identify breath biomarkers to detect and differentiate early-stage disease.
      Owlstone Medical 01.03.19

    • PROCEPT BioRobotics Appoints Chief Financial Officer

      PROCEPT BioRobotics Appoints Chief Financial Officer

      New hire most recently served as senior vice president and chief financial officer of Accuray Inc.
      Business Wire 12.19.18


      Trending
      • 5 Ways Plastics Revolutionized The Healthcare Industry | Medical Product Outsourcing
      • Philips Recalls CPAP, BiPAP Over Debris And Chemical Exposure Risk | Medical Product Outsourcing
      • ASSURE Touts Positive Clinical Results For Its Wearable Cardioverter Defibrillator | Medical Product Outsourcing
      • Smart LED Contact Lens Diagnoses Diabetes & Treats Retinopathy | Medical Product Outsourcing
      • FDA Clears Innovia Medical's Sterizone VP4 Sterilization Process | Medical Product Outsourcing
      Breaking News
      • Iterative Scopes Expands its Senior Leadership Team
      • Viz.ai Raises $100 Million in Series D Funding
      • FDA Clears Arterys' AI Mapping and Quantification Tools
      • Prometheus Group Sued Over Reused Catheters and Rectal Sensors
      • VenoStent's SelfWrap Bioabsorbable Perivascular Wrap Earns Breakthrough Status
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      ÄZ Craft Luxury Haircare Products Support All Hairstyles
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login